Morgan Stanley Cellebrite Di Ltd. Transaction History
Morgan Stanley
- $1.36 Trillion
- Q1 2025
A detailed history of Morgan Stanley transactions in Cellebrite Di Ltd. stock. As of the latest transaction made, Morgan Stanley holds 3,963,259 shares of CLBT stock, worth $66.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,963,259
Previous 5,162,807
23.23%
Holding current value
$66.7 Million
Previous $114 Million
32.29%
% of portfolio
0.01%
Previous 0.01%
Shares
23 transactions
Others Institutions Holding CLBT
# of Institutions
211Shares Held
90.8MCall Options Held
177KPut Options Held
84.2K-
True Wind Capital Management, L.P.13.9MShares$233 Million92.82% of portfolio
-
Acadian Asset Management LLC Boston, MA3.92MShares$66 Million0.22% of portfolio
-
Voss Capital, LLC Houston, TX3.84MShares$64.7 Million6.97% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L33.34MShares$56.3 Million0.67% of portfolio
-
Invesco Ltd. Atlanta, GA3.3MShares$55.5 Million0.01% of portfolio
About Cellebrite DI Ltd.
- Ticker CLBT
- Exchange NASDAQ
- Sector Technology
- Industry Software—Infrastructure
- Shares Outstandng 189,648,992
- Market Cap $3.19B
- Description
- Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border c...